{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:10:23Z","timestamp":1790831423185,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.jneuroim.2004.10.018","type":"journal-article","created":{"date-parts":[[2004,12,28]],"date-time":"2004-12-28T18:59:44Z","timestamp":1104260384000},"page":"230-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert\u2013Eaton myasthenic syndrome"],"prefix":"10.1016","volume":"159","author":[{"given":"Paul W.","family":"Wirtz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Willcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno R.","family":"van der Slik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethan","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Maddison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobby P.C.","family":"Koeleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius J.","family":"Giphart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel R.","family":"Wintzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart O.","family":"Roep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.G.M.","family":"Verschuuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2004.10.018_bib1","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1084\/jem.182.6.1703","article-title":"T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen","volume":"182","author":"Burrows","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2004.10.018_bib2","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1212\/WNL.40.10.1552","article-title":"Response of the Lambert\u2013Eaton myasthenic syndrome to treatment of associated small-cell lung carcinoma","volume":"40","author":"Chalk","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2004.10.018_bib3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ni0303-201","article-title":"Observing the invisible: successful tumor immunity in humans","volume":"4","author":"Darnell","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2004.10.018_bib4","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2004.10.018_bib5","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/jnnp.54.9.764","article-title":"Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients","volume":"54","author":"Elrington","year":"1991","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2004.10.018_bib6","series-title":"Statistics Netherlands","article-title":"Mannen roken minder, vrouwen niet","author":"Frenken","year":"2003"},{"key":"10.1016\/j.jneuroim.2004.10.018_bib7","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1200\/JCO.1997.15.8.2866","article-title":"Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival","volume":"15","author":"Graus","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jneuroim.2004.10.018_bib8","series-title":"HLA 1997","first-page":"208","article-title":"Caucasian English normal","author":"Haworth","year":"1997"},{"key":"10.1016\/j.jneuroim.2004.10.018_bib9","series-title":"HLA 1998","first-page":"133","article-title":"Caucasian English normal","author":"Haworth","year":"1998"},{"key":"10.1016\/j.jneuroim.2004.10.018_bib10","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0198-8859(99)00062-2","article-title":"A susceptibility region for myasthenia gravis extending into the HLA- class I sector telomeric to HLA-C","volume":"60","author":"Janer","year":"1999","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jneuroim.2004.10.018_bib11","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJM199506013322203","article-title":"Calcium-channel antibodies in the Lambert\u2013Eaton syndrome and other paraneoplastic syndromes","volume":"332","author":"Lennon","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2004.10.018_bib12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0198-8859(01)00264-6","article-title":"A genetically determined high setting of TNF-alpha influences immunologic parameters of HLA-B8,DR3 positive subjects: implications for autoimmunity","volume":"62","author":"Lio","year":"2001","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jneuroim.2004.10.018_bib13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1006\/clim.1999.4710","article-title":"Correlation of thymic pathology with HLA in myasthenia gravis","volume":"91","author":"Machens","year":"1999","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2004.10.018_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(05)76153-5","article-title":"Favourable prognosis in Lambert\u2013Eaton myasthenic syndrome and small-cell lung carcinoma","volume":"353","author":"Maddison","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2004.10.018_bib15","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1002\/1097-0142(19841215)54:12<2943::AID-CNCR2820541221>3.0.CO;2-#","article-title":"Histocompatibility antigens in small cell carcinoma of the lung","volume":"54","author":"Markman","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.jneuroim.2004.10.018_bib16","first-page":"839","article-title":"Immunocytochemical characteristics of small cell lung carcinoma associated with the Lambert\u2013Eaton myasthenic syndrome","volume":"140","author":"Morris","year":"1992","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2004.10.018_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-510X(96)05303-8","article-title":"Incidence of serum anti-P\/O-type and anti-N-type calcium channel autoantibodies in the Lambert\u2013Eaton myasthenic syndrome","volume":"147","author":"Motomura","year":"1997","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2004.10.018_bib18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/111.3.577","article-title":"The Lambert\u2013Eaton myasthenic syndrome. A review of 50 cases","volume":"111","author":"O'Neill","year":"1988","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2004.10.018_bib19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/1097-0142(20000801)89:3<523::AID-CNCR7>3.0.CO;2-6","article-title":"Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years","volume":"89","author":"Paesmans","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.jneuroim.2004.10.018_bib20","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0198-8859(00)00135-X","article-title":"Increased frequency of HLA class II alleles DRB1*0301 and DQB1*0201 in Lambert\u2013Eaton myasthenic syndrome without associated cancer","volume":"61","author":"Parsons","year":"2000","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jneuroim.2004.10.018_bib21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1600-065X.1999.tb01398.x","article-title":"The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases","volume":"167","author":"Price","year":"1999","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2004.10.018_bib22","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/317737a0","article-title":"Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line","volume":"317","author":"Roberts","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2004.10.018_bib23","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1399-0039.1996.tb02670.x","article-title":"HLA gene and haplotype frequencies in Dutch blood donors","volume":"48","author":"Schipper","year":"1996","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jneuroim.2004.10.018_bib24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1212\/WNL.50.2.565","article-title":"Lack of association between human leukocyte antigens and the anti-Hu syndrome in patients with small-cell lung cancer","volume":"50","author":"Uchuya","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2004.10.018_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0198-8859(85)90062-X","article-title":"Increased frequency of IgG heavy chain marker Glm(2) and of HLA-B8 in Lambert\u2013Eaton myasthenic syndrome with and without associated lung carcinoma","volume":"14","author":"Willcox","year":"1985","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jneuroim.2004.10.018_bib26","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0198-8859(01)00270-1","article-title":"HLA class I and II in Lambert\u2013Eaton myasthenic syndrome without associated tumor","volume":"62","author":"Wirtz","year":"2001","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jneuroim.2004.10.018_bib27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0165-5728(03)00205-4","article-title":"High innate production of interleukin-10 and tumor necrosis factor-alfa contributes to susceptibility for non-paraneoplastic Lambert\u2013Eaton myasthenic syndrome","volume":"140","author":"Wirtz","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2004.10.018_bib28","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3109\/07357909309024856","article-title":"Spontaneous regression of small cell carcinoma of lung associated with severe neuropathy","volume":"11","author":"Zaheer","year":"1993","journal-title":"Cancer Investig."},{"key":"10.1016\/j.jneuroim.2004.10.018_bib29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0198-8859(00)00227-5","article-title":"The telomeric part of the HLA region predisposes to rheumatoid arthritis independently of the class II loci","volume":"62","author":"Zanelli","year":"2001","journal-title":"Hum. Immunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572804003807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572804003807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:02:18Z","timestamp":1759046538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572804003807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":29,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0165572804003807"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2004.10.018","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert\u2013Eaton myasthenic syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2004.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}